Search research articles
Contact Us
Filters
Showing results (11-20 of 33) with videos related to
Page
of 4
Sort By:
British Journal of Cancer
|
March 5, 2002
Sequential or alternating administration of docetaxel (Taxotere) combined with FEC in metastatic breast cancer: a randomised phase II trial
M Spielmann, M Tubiana-Hulin, M Namer, et al.
Prostate Cancer and Prostatic Diseases
|
October 15, 2014
Who dies from prostate cancer?
A Patrikidou, Y Loriot, J-C Eymard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 17, 2007
Randomized phase II study of docetaxel plus estramustine and single-agent docetaxel in patients with metastatic hormone-refractory prostate cancer
J-C Eymard, F Priou, A Zannetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 10, 2011
Could thyroid dysfunction influence outcome in sunitinib-treated metastatic renal cell carcinoma?
R Sabatier, J C Eymard, J Walz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 6, 2014
Combining gemcitabine, cisplatin, and ifosfamide (GIP) is active in patients with relapsed metastatic germ-cell tumors (GCT): a prospective multicenter GETUG phase II trial
K Fizazi, G Gravis, A Flechon, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 10, 1998
Simultaneous high-dose external irradiation and daily cisplatin in unresectable, non-metastatic adenocarcinoma of the pancreas: a phase I-II study
T D Nguyen, S Theobald, P Rougier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 2, 2014
Translational studies within the TAMRAD randomized GINECO trial: evidence for mTORC1 activation marker as a predictive factor for everolimus efficacy in advanced breast cancer
I Treilleux, M Arnedos, C Cropet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 4, 2014
Outcomes from second-line therapy in long-term responders to first-line tyrosine kinase inhibitor in clear-cell metastatic renal cell carcinoma
R Elaidi, A Harbaoui, B Beuselinck, et al.
The Journal of Urology
|
August 21, 2002
Doxorubicin and ifosfamide in patients with metastatic sarcomatoid renal cell carcinoma: a phase II study of the Genitourinary Group of the French Federation of Cancer Centers
B Escudier, J P Droz, F Rolland, et al.
British Journal of Cancer
|
May 17, 2007
Epirubicin-vinorelbine vs FEC100 for node-positive, early breast cancer: French Adjuvant Study Group 09 trial
P Kerbrat, H Roché, J Bonneterre, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 33) with videos related to
Sort By:
Page
of 4
British Journal of Cancer
|
March 5, 2002
Sequential or alternating administration of docetaxel (Taxotere) combined with FEC in metastatic breast cancer: a randomised phase II trial
M Spielmann, M Tubiana-Hulin, M Namer, et al.
Prostate Cancer and Prostatic Diseases
|
October 15, 2014
Who dies from prostate cancer?
A Patrikidou, Y Loriot, J-C Eymard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 17, 2007
Randomized phase II study of docetaxel plus estramustine and single-agent docetaxel in patients with metastatic hormone-refractory prostate cancer
J-C Eymard, F Priou, A Zannetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 10, 2011
Could thyroid dysfunction influence outcome in sunitinib-treated metastatic renal cell carcinoma?
R Sabatier, J C Eymard, J Walz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 6, 2014
Combining gemcitabine, cisplatin, and ifosfamide (GIP) is active in patients with relapsed metastatic germ-cell tumors (GCT): a prospective multicenter GETUG phase II trial
K Fizazi, G Gravis, A Flechon, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 10, 1998
Simultaneous high-dose external irradiation and daily cisplatin in unresectable, non-metastatic adenocarcinoma of the pancreas: a phase I-II study
T D Nguyen, S Theobald, P Rougier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 2, 2014
Translational studies within the TAMRAD randomized GINECO trial: evidence for mTORC1 activation marker as a predictive factor for everolimus efficacy in advanced breast cancer
I Treilleux, M Arnedos, C Cropet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 4, 2014
Outcomes from second-line therapy in long-term responders to first-line tyrosine kinase inhibitor in clear-cell metastatic renal cell carcinoma
R Elaidi, A Harbaoui, B Beuselinck, et al.
The Journal of Urology
|
August 21, 2002
Doxorubicin and ifosfamide in patients with metastatic sarcomatoid renal cell carcinoma: a phase II study of the Genitourinary Group of the French Federation of Cancer Centers
B Escudier, J P Droz, F Rolland, et al.
British Journal of Cancer
|
May 17, 2007
Epirubicin-vinorelbine vs FEC100 for node-positive, early breast cancer: French Adjuvant Study Group 09 trial
P Kerbrat, H Roché, J Bonneterre, et al.
Page
of 4